Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
FGF23 in chronic kidney disease
Patricia Wahl, Myles Wolf
*
*
Corresponding author for this work
Medicine, Nephrology Division
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
57
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'FGF23 in chronic kidney disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
diseases
100%
fibroblasts
100%
kidneys
100%
growth factors
100%
levels
57%
metabolism
57%
phosphorus
57%
mortality
28%
phosphates
28%
tissues
14%
patients
14%
risks
14%
balances
14%
production
14%
management
14%
public health
14%
hypertrophy
14%
minerals
14%
biological markers
14%
investigations
14%
injuries
14%
vessels
14%
vitamin d
14%
Medicine and Dentistry
Chronic Kidney Disease
100%
Fibroblast Growth Factor 23
100%
Serum
33%
Phosphate
33%
Phosphate Metabolism
33%
Phosphorus
33%
Calcitriol
16%
Biological Marker
16%
Left Ventricular Hypertrophy
16%
Tissue Injury
16%
Epidemic
16%
Cardiovascular Mortality
16%
Endothelial Dysfunction
16%
Mineral Metabolism
16%
Mortality
16%
Vitamin D Metabolism
16%
Phosphaturia
16%
Physiological Adaptation
16%
Patient
16%
Kidney
16%
Public Health
16%
Heart
16%
Biochemistry, Genetics and Molecular Biology
Fibroblast Growth Factor 23
100%
Phosphate Metabolism
33%
Phosphate Blood Level
33%
Calcitriol
16%
Vitamin D Metabolism
16%
Adaptation
16%
Cardiovascular Mortality
16%
Health
16%
Mortality
16%